DNLI logo

Denali Therapeutics (DNLI) Current Liabilities

Annual Current Liabilities

$77.98 M
-$285.94 M-78.57%

December 31, 2023


Summary


Performance

DNLI Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDNLIbalance sheetmetrics:

Quarterly Current Liabilities

$87.09 M
+$12.56 M+16.85%

September 30, 2024


Summary


Performance

DNLI Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDNLIbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

DNLI Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-78.6%+16.9%
3 y3 years+8.8%-76.1%
5 y5 years+137.8%-76.1%

DNLI Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-79.4%at low-77.7%+25.6%
5 y5-year-79.4%+72.0%-77.7%+92.1%
alltimeall time-79.4%+2140.2%-77.7%+856.4%

Denali Therapeutics Current Liabilities History

DateAnnualQuarterly
Sep 2024
-
$87.09 M(+16.9%)
Jun 2024
-
$74.53 M(-9.7%)
Mar 2024
-
$82.58 M(+5.9%)
Dec 2023
$77.98 M(-78.6%)
$77.98 M(+9.6%)
Sep 2023
-
$71.18 M(+2.6%)
Jun 2023
-
$69.36 M(-82.3%)
Mar 2023
-
$391.08 M(+7.5%)
Dec 2022
$363.92 M(-3.8%)
$363.92 M(+0.9%)
Sep 2022
-
$360.67 M(+3.6%)
Jun 2022
-
$348.16 M(+2.0%)
Mar 2022
-
$341.24 M(-9.8%)
Dec 2021
$378.25 M(+427.5%)
$378.25 M(+597.2%)
Sep 2021
-
$54.25 M(+5.5%)
Jun 2021
-
$51.41 M(-5.9%)
Mar 2021
-
$54.61 M(-23.8%)
DateAnnualQuarterly
Dec 2020
$71.70 M(+58.1%)
$71.70 M(-32.0%)
Sep 2020
-
$105.41 M(+80.3%)
Jun 2020
-
$58.46 M(+22.7%)
Mar 2020
-
$47.63 M(+5.1%)
Dec 2019
$45.34 M(+38.3%)
$45.34 M(-2.9%)
Sep 2019
-
$46.69 M(+0.3%)
Jun 2019
-
$46.55 M(+7.6%)
Mar 2019
-
$43.24 M(+31.9%)
Dec 2018
$32.79 M(+131.5%)
$32.79 M(+3.7%)
Sep 2018
-
$31.62 M(+2.0%)
Jun 2018
-
$31.01 M(+80.6%)
Mar 2018
-
$17.17 M(+21.2%)
Dec 2017
$14.16 M(+55.5%)
$14.16 M(+39.5%)
Sep 2017
-
$10.15 M(+11.5%)
Dec 2016
$9.11 M(+161.6%)
$9.11 M
Dec 2015
$3.48 M
-

FAQ

  • What is Denali Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Denali Therapeutics?
  • What is Denali Therapeutics annual current liabilities year-on-year change?
  • What is Denali Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Denali Therapeutics?
  • What is Denali Therapeutics quarterly current liabilities year-on-year change?

What is Denali Therapeutics annual total current liabilities?

The current annual current liabilities of DNLI is $77.98 M

What is the all time high annual current liabilities for Denali Therapeutics?

Denali Therapeutics all-time high annual total current liabilities is $378.25 M

What is Denali Therapeutics annual current liabilities year-on-year change?

Over the past year, DNLI annual total current liabilities has changed by -$285.94 M (-78.57%)

What is Denali Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of DNLI is $87.09 M

What is the all time high quarterly current liabilities for Denali Therapeutics?

Denali Therapeutics all-time high quarterly total current liabilities is $391.08 M

What is Denali Therapeutics quarterly current liabilities year-on-year change?

Over the past year, DNLI quarterly total current liabilities has changed by +$12.56 M (+16.85%)